Method of treatment of gastrointestinal-type cancer with antagonistic antibodies to IL-11R
The present invention relates generally to the field of cancer therapy. More particularly, the present invention provides a method for the treatment of gastrointestinal-type cancers and therapeutic agents useful for same.
1. A method for the treatment of a gastrointestinal-type cancer in a subject, said method comprising administering to said subject an interleukin-11 receptor (IL-11R)-specific antagonostic antibody in an amount effective to treat said gastrointestinal-type cancer.
2. The method of claim 1 wherein the gastrointestinal-type cancer is gastric cancer or colorectal cancer.
3. The method of claim 1 wherein the amount of IL-11R-specific antibody is an amount that inhibits or reduces activation of STAT3 and/or STAT1.
4. The method of claim 1 wherein the subject is a human.
5. The method of claim 1 further comprising the administration of an anti-cancer agent.
6. The method of claim 1 further comprising radiation therapy or surgical ablation of cancer tissue.